Cargando…
Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period
BACKGROUND: An increasing number of observational studies have reported the persistence of symptoms following recovery from acute COVID-19 disease in non-cancer patients. The long-term consequences of COVID-19 are not fully understood particularly in the cancer patient population. The purpose of thi...
Autores principales: | Dagher, Hiba, Chaftari, Anne-Marie, Subbiah, Ishwaria M, Malek, Alexandre E, Jiang, Ying, Lamie, Peter, Granwehr, Bruno, John, Teny, Yepez, Eduardo, Borjan, Jovan, Reyes-Gibby, Cielito, Flores, Mary, Khawaja, Fareed, Pande, Mala, Ali, Noman, Rojo, Raniv, Karp, Daniel D, Chaftari, Patrick, Hachem, Ray, Raad, Issam I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977271/ https://www.ncbi.nlm.nih.gov/pubmed/36748905 http://dx.doi.org/10.7554/eLife.81182 |
Ejemplares similares
-
300. Long COVID in Cancer Patients: Preponderance of Symptoms in Majority of Patients Over Long Time Period
por: Dagher, Hiba, et al.
Publicado: (2021) -
859. The Role of Procalcitonin in Antimicrobial De-escalation and Stewardship Program in Febrile Neutropenic Cancer Patients
por: Dagher, Hiba, et al.
Publicado: (2023) -
363. A Phase II Prospective Randomized Study to Assess Imipenem-Relebactam in the Management of Cancer Patients with Febrile Neutropenia
por: Chaftari, Anne-Marie, et al.
Publicado: (2023) -
1636. Risk of Latent Tuberculosis Reactivation in Patients Treated with Checkpoint Inhibitors Immunotherapy Compared to Other Anti-Cancer Therapies including Hematopoietic Cell Transplantation
por: Malek, Alexandre, et al.
Publicado: (2020) -
International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship
por: Raad, Issam I, et al.
Publicado: (2023)